Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
University of Chicago
BeOne Medicines
University of Washington
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
BeOne Medicines
Dartmouth-Hitchcock Medical Center
Hutchmed
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Acerta Pharma BV
Acerta Pharma BV
Eli Lilly and Company
Incyte Corporation
National Institutes of Health Clinical Center (CC)
AstraZeneca
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Diego
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Acerta Pharma BV
City of Hope Medical Center
Hoffmann-La Roche
University of Washington
Thomas Jefferson University
Dana-Farber Cancer Institute
University of California, San Diego
M.D. Anderson Cancer Center
University of California, San Diego
M.D. Anderson Cancer Center
Acerta Pharma BV
City of Hope Medical Center
Center for International Blood and Marrow Transplant Research
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
American Regent, Inc.
City of Hope Medical Center